Martin Shkreli Violated Lifetime Pharmaceutical Industry Ban, FTC Finds

Martin Shkreli, previously banned from the pharmaceutical industry for orchestrating an illegal monopoly scheme involving the drug Daraprim, has been found by the FTC to have violated this lifetime ban. This decision follows a trial that exposed his role in perpetuating the monopoly. The FTC's finding underscores ongoing regulatory enforcement in the pharmaceutical sector.

Originally published by gnews